Contact
Please use this form to send email to PR contact of this press release:
Panacea Life Sciences, Inc Closes Series A Investment Round with 22nd Century Group to Expand CBD Operations
TO:
Nicholas J. Cavarra
Panacea Life Sciences, Inc.
+1 303-886-5538